|Market Cap (Intraday)||485.74M|
|2yr Forward PE||124.62|
XBiotech Inc Stock, NASDAQ:XBIT
XBiotech, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutic antibodies. Its product pipeline includes oncology, infectious diseases, dermatology and inflammatory disorders. The company was founded by John Simard on March 22, 2005 and is headquartered in Austin, TX.